845 related articles for article (PubMed ID: 26477826)
1. Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience.
Gilling P; Reuther R; Kahokehr A; Fraundorfer M
BJU Int; 2016 Jun; 117(6):923-9. PubMed ID: 26477826
[TBL] [Abstract][Full Text] [Related]
2. Prostatic hydroablation (Aquablation): A new effective ultrasound guided robotic waterjet ablative surgery for treatment of benign prostatic hyperplasia.
Lim Ng K; Barber N
Arch Esp Urol; 2019 Oct; 72(8):786-793. PubMed ID: 31579037
[TBL] [Abstract][Full Text] [Related]
3. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
[TBL] [Abstract][Full Text] [Related]
4. Initial single centre experience of Aquablation of the prostate using the AquaBeam system with athermal haemostasis for the treatment of benign prostatic hyperplasia: 1-year outcomes.
Whiting D; Ng KL; Barber N
World J Urol; 2021 Aug; 39(8):3019-3024. PubMed ID: 33392647
[TBL] [Abstract][Full Text] [Related]
5. Aquablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: 1-Year Results.
Gilling P; Anderson P; Tan A
J Urol; 2017 Jun; 197(6):1565-1572. PubMed ID: 28111300
[TBL] [Abstract][Full Text] [Related]
6. Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostates.
Nguyen DD; Barber N; Bidair M; Gilling P; Anderson P; Zorn KC; Badlani G; Humphreys M; Kaplan S; Kaufman R; So A; Paterson R; Goldenberg L; Elterman D; Desai M; Lingeman J; Roehrborn C; Bhojani N
BJU Int; 2020 Jan; 125(1):112-122. PubMed ID: 31599044
[TBL] [Abstract][Full Text] [Related]
7. Waterjet Ablation Therapy for Treating Benign Prostatic Obstruction in Patients with Small- to Medium-size Glands: 12-month Results of the First French Aquablation Clinical Registry.
Misrai V; Rijo E; Zorn KC; Barry-Delongchamps N; Descazeaud A
Eur Urol; 2019 Nov; 76(5):667-675. PubMed ID: 31281024
[TBL] [Abstract][Full Text] [Related]
8. WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation
Gilling P; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Kaufman RP; Trainer A; Arther A; Badlani G; Plante M; Desai M; Doumanian L; Te AE; DeGuenther M; Roehrborn C
J Urol; 2018 May; 199(5):1252-1261. PubMed ID: 29360529
[TBL] [Abstract][Full Text] [Related]
9. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation.
Nguyen DD; Li T; Ferreira R; Baker Berjaoui M; Nguyen AV; Chughtai B; Zorn KC; Bhojani N; Elterman D
Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):22-28. PubMed ID: 37081044
[TBL] [Abstract][Full Text] [Related]
10. Aquablation outcomes for the U.S. cohort of men with LUTS due to BPH in large prostates (80-150 cc).
Yafi FA; Tallman CT; Seard ML; Jordan ML
Int J Impot Res; 2018 Oct; 30(5):209-214. PubMed ID: 30046163
[TBL] [Abstract][Full Text] [Related]
11. Aquablation of the Prostate for Symptomatic Benign Prostatic Hyperplasia: Early Results.
Yassaie O; Silverman JA; Gilling PJ
Curr Urol Rep; 2017 Oct; 18(12):91. PubMed ID: 29046995
[TBL] [Abstract][Full Text] [Related]
12. Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial.
Plante M; Gilling P; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Kaufman RP; Trainer A; Arther A; Badlani G; Desai M; Doumanian L; Te AE; DeGuenther M; Roehrborn C
BJU Int; 2019 Apr; 123(4):651-660. PubMed ID: 29862630
[TBL] [Abstract][Full Text] [Related]
13. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
[TBL] [Abstract][Full Text] [Related]
14. Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH.
Gilling PJ; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Kaufman RP; Badlani G; Plante M; Desai M; Doumanian L; Te AE; Roehrborn CG
Can J Urol; 2022 Feb; 29(1):10960-10968. PubMed ID: 35150215
[TBL] [Abstract][Full Text] [Related]
15. Aquablation therapy for symptomatic benign prostatic hyperplasia: a single-centre experience in 47 patients.
Desai MM; Singh A; Abhishek S; Laddha A; Pandya H; Ashrafi AN; Ganpule AP; Roehrborn CG; Thomas AJ; Desai M; Sabnis RB
BJU Int; 2018 Jun; 121(6):945-951. PubMed ID: 29319914
[TBL] [Abstract][Full Text] [Related]
16. Comparison of < 100 cc prostates and > 100 cc prostates undergoing aquablation for benign prostatic hyperplasia.
Bhojani N; Nguyen DD; Kaufman RP; Elterman D; Zorn KC
World J Urol; 2019 Jul; 37(7):1361-1368. PubMed ID: 30370457
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
Elshal AM; Elmansy HM; Elhilali MM
BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
[TBL] [Abstract][Full Text] [Related]
18. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
[TBL] [Abstract][Full Text] [Related]
19. How I do it: Aquablation of the prostate using the AQUABEAM system.
MacRae C; Gilling P
Can J Urol; 2016 Dec; 23(6):8590-8593. PubMed ID: 27995858
[TBL] [Abstract][Full Text] [Related]
20. Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia: One-year Outcomes.
Gilling PJ; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Roehrborn C
Urology; 2019 Mar; 125():169-173. PubMed ID: 30552937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
